TAKE Solutions Limited (TAKE) AI Stock Analysis

4 Followers

TAKE Solutions Limited

(NSE:TAKE)

Select Model

Rating:39Underperform

Price Target:INR 10.50▼(-18.79% Downside)

Action:downgraded

Date:10/01/26

The overall score is very low, driven primarily by a fragile financial state where the company is not generating cash from its core operations despite a cleaned-up balance sheet. This is compounded by a strongly bearish technical trend, with the stock in a sustained downtrend and showing no signs of reversal. The seemingly normal P/E ratio is deceptive as earnings are not derived from the main business.

Positive Factors

Life-sciences specializationTAKE’s focused positioning in life sciences gives it a defined domain niche rather than a completely generalist services profile. Expertise across clinical, regulatory, quality, supply-chain, and commercial processes can support relevance with regulated-industry clients over the medium term.

Negative Factors

Negative core profitabilityNegative gross and operating profit indicate that the core business was not economically profitable in FY2026. Positive net income appears to have been driven by below-the-line items, making reported earnings less dependable and limiting confidence in sustainable operating performance.

TAKE Solutions Limited (TAKE) vs. iShares MSCI India ETF (INDA)

Market Cap: INR 1.69B
Dividend Yield: ―
Average Volume (3M): 88.38K
Price to Earnings (P/E): 15.0
Beta (1Y): 1.46
Revenue Growth: ―
EPS Growth: -82.03%
Country: India
Employees: 5
Sector: General
Sector Strength: 55
Industry: Information Technology Services

TAKE Solutions Limited Business Overview & Revenue Model

Company Description

TAKE Solutions Limited, operating across the United States, Asia Pacific, and Europe, specializes in providing expert services and cutting-edge solutions for the life sciences and supply chain management sectors. For the life sciences industry, the c...

How the Company Makes Money

TAKE primarily makes money by selling technology and services to clients in regulated life-sciences markets. Key revenue streams typically include (1) services revenue from IT consulting, implementation, customization, validation, and ongoing managed...

TAKE Solutions Limited Financial Statement Overview

Summary

Financial performance is critically weak. Revenue has collapsed, core operations are deeply unprofitable with negative gross margins, and operating cash flow is negative. While the balance sheet is now debt-free, the inability to generate cash from operations presents a severe risk to sustainability.

Income Statement

20Very Negative

Balance Sheet

60Neutral

Cash Flow

15Very Negative

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	845.59M	541.85M	0	656.08M	1.89B	6.53B
Gross Profit	-36.00K	-4.44M	-450.00K	411.67M	1.06B	4.60B
EBITDA	-19.02M	-19.14M	27.44M	-1.05B	-209.79M	269.00M
Net Income	128.22M	108.49M	374.67M	-1.20B	-1.00B	-7.82B
Balance Sheet
Total Assets	0	362.41M	364.79M	881.05M	2.24B	12.23B
Cash, Cash Equivalents and Short-Term Investments	2.80M	184.41M	156.91M	8.49M	113.36M	290.71M
Total Debt	0	0	0	370.85M	463.69M	779.90M
Total Liabilities	-310.01M	52.40M	159.52M	969.78M	1.16B	10.42B
Stockholders Equity	310.01M	310.01M	205.27M	-88.73M	1.09B	1.81B
Cash Flow
Free Cash Flow	-31.39M	0	-163.66M	14.00M	-123.81M	890.99M
Operating Cash Flow	-31.39M	-27.76M	-163.66M	93.16M	200.15M	1.20B
Investing Cash Flow	270.00K	1,000	220.20M	-74.62M	-21.25M	-306.41M
Financing Cash Flow	-130.00K	-3.75M	-32.39M	-117.35M	-357.21M	-545.17M

TAKE Solutions Limited Technical Analysis

Technical Analysis SentimentNeutral

Last Price12.93

Price Trends

50DMA13.44Negative

100DMA17.92Negative

200DMA28.20Negative

Market Momentum

MACD-0.21Negative

RSI54.18Neutral

STOCH78.57Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:TAKE, the sentiment is Neutral. The current price of 12.93 is above the 20-day moving average (MA) of 11.69, below the 50-day MA of 13.44, and below the 200-day MA of 28.20, indicating a neutral trend. The MACD of -0.21 indicates Negative momentum. The RSI at 54.18 is Neutral, neither overbought nor oversold. The STOCH value of 78.57 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:TAKE.

TAKE Solutions Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IN:TAKE against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IN:SYNGENE	67Neutral	INR 180.70B	95.96	―	0.28%	-5.99%	-60.30%
IN:CONCORDBIO	61Neutral	INR 125.76B	44.05	―	1.27%	4.02%	-12.81%
IN:DCAL	57Neutral	INR 27.28B	39.75	―	―	-20.86%	-34.51%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
IN:ONESOURCE	48Neutral	INR 185.42B	-10734.00	―	―	10.66%	-104.59%
IN:BIOCON	47Neutral	INR 604.03B	121.75	―	0.14%	5.70%	-24.72%
IN:TAKE	39Underperform	INR 1.92B	14.97	―	―	―	-82.03%

* General Sector Average

Performance Comparison

IN:TAKE and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IN:TAKE	TAKE Solutions Limited	12.93	-16.52	-56.10%
IN:BIOCON	Biocon Limited	366.80	-54.00	-12.83%
IN:CONCORDBIO	Concord Biotech Ltd.	594.50	-151.73	-20.33%
IN:DCAL	Dishman Carbogen Amcis Ltd.	173.90	-77.55	-30.84%
IN:SYNGENE	Syngene International Ltd.	444.70	-205.06	-31.56%
IN:ONESOURCE	OneSource Specialty Pharma Limited	1613.45	-171.70	-9.62%

TAKE Solutions Limited Corporate Events

TAKE Limited Appoints New Internal Auditor for FY 2025-26

Sep 1, 2026

TAKE Limited’s board has approved the appointment of M/s. Tejas Nadkarni & Associates, a Mumbai-based firm of chartered accountants, as the company’s internal auditor for the financial year 2025-26, effective September 1, 2026. The one-year appointme...

TAKE Limited Shareholders Approve Appointment of New Managing Director via Postal Ballot

Aug 17, 2026

TAKE Limited has announced the results of a postal ballot process conducted via remote e-voting and physical ballot forms, undertaken pursuant to Indian listing regulations. The company reported that the resolution to appoint Mr. Sunil Patra as Manag...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 01, 2026

TAKE Solutions Limited AI Stock Analysis